Ahwazi D, Neopane K, Markby G, Kopietz F, Ovens A, Dall M, et al. Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965. Biochem J. 2021;478:2977-2997 pubmed publisher

Xiao C, Liu N, Jacobson K, Gavrilova O, Reitman M. Physiology and effects of nucleosides in mice lacking all four adenosine receptors. PLoS Biol. 2019;17:e3000161 pubmed publisher

Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A, et al. Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor. Blood. 2016;128:2717-2728 pubmed

Baron L, Gombault A, Fanny M, Villeret B, Savigny F, Guillou N, et al. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death Dis. 2015;6:e1629 pubmed publisher

Clasadonte J, McIver S, Schmitt L, Halassa M, Haydon P. Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosine. J Neurosci. 2014;34:1879-91 pubmed publisher

Mandapathil M, Szczepanski M, Harasymczuk M, Ren J, Cheng D, Jackson E, et al. CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma. Oncoimmunology. 2012;1:659-669 pubmed